Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab vs PRP for Proliferative Diabetic Retinopathy
NCT02705274Phase 3Completed
- Sponsor
- Marashi Eye Clinic
- Start
- Feb 2016
- Primary completion
- Apr 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in proliferative diabetic retinopathy (PDR), sponsored by Marashi Eye Clinic. Started Feb 2016; status: completed.
02
Drugs
bevacizumab
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT02705274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02705274.